Delivery Order SPE2DB22D2214-SPE2DB24FS5TM
Award Date
7/10/24
Potential Completion Date
7/11/24
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $1,902.08 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,310,884 capsules of Tamsulosin HCL 0.4 mg. This order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 1,000 capsules of Tamsulosin HCl 0.4 mg. The $5,622.40 award is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide pharmaceutical products and medical supplies to support Department of Defense military treatment facilities...
The U.S. Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,697.77 to provide 1,000 units of the generic pharmaceutical drug Tamsulosin HCl 0.4 mg capsules. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,261,614 units of the pharmaceutical drug Tamsulosin HCL 0.4 mg capsules. The $2,310.04 award has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA valued at up to $999,999,999.00, through which this delivery order was issued. The contract...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,001,477 capsules of the generic drug tamsulosin hydrochloride 0.4 mg. The $3,324.39 contract has a performance period through March 19, 2024. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. This award is associated with a larger indefinite delivery contract between...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,554.64 firm fixed price delivery order is for the supply of 4,564,702,627 units of the medication Tamsulosin HCl 0.4 mg capsules. The contract has an ultimate completion date of May 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,610,559 capsules of Tamsulosin HCl 0.4 mg. The contract has a completion date of February 12, 2024 and a potential value of $2,459.44. This award is under a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a maximum potential value of $999,999,999.00 through December 31,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division was issued by the Defense Logistics Agency (DLA) for the delivery of 4,566,086,886 units of the prescription drug Tamsulosin HCl 0.4 mg capsules. The $3,502.99 fixed-price delivery order has an ultimate completion date of October 15, 2024. Amerisourcebergen, a leading pharmaceutical distributor, has been awarded this contract under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), which is...
The Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order valued at $4,202.05 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The order is for the supply of 1,000 units of tamsulosin hydrochloride 0.4 mg capsules, with a completion date of February 5, 2024. This order is issued under an existing indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of...
This contract award, valued at $9,430.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distribution company, for the supply of 4,564,286,765 capsules of the medication Tamsulosin HCL 0.4 mg. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 16, 2024. Amerisourcebergen Drug Corporation is the Corporate Office division of Amerisourcebergen Corporation, one of the largest pharmaceutical...